CONCORD BIOTECH DRHP
Rare Enterprises, Quadria-backed Concord Biotech files draft IPO papers with SebiAs per an F&S report, Concord Biotech commands a market share of over 20 per cent by volume in 2021 across identified fermentation-based AP...16 Aug, 2022, 03.39 PM IST
Load More